Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jack Antel

Showing results (71-80 of 99) with videos related to

Pageof 10
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|August 21, 2021
Pro-inflammatory T helper 17 directly harms oligodendrocytes in neuroinflammationCatherine Larochelle, Beatrice Wasser, Hélène Jamann, et al.
Annals of Neurology|October 23, 2009
Rituximab in patients with primary progressive multiple sclerosis: results of a randomized double-blind placebo-controlled multicenter trialKathleen Hawker, Paul O'Connor, Mark S Freedman, et al.
The New England Journal of Medicine|February 15, 2008
B-cell depletion with rituximab in relapsing-remitting multiple sclerosisStephen L Hauser, Emmanuelle Waubant, Douglas L Arnold, et al.
Immunology and Cell Biology|October 19, 2022
Granulocyte-macrophage colony-stimulating factor-stimulated human macrophages demonstrate enhanced functions contributing to T-cell activationNegar Farzam-Kia, Florent Lemaître, Ana Carmena Moratalla, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 8, 2017
Sphingosine 1-phosphate receptor modulation suppresses pathogenic astrocyte activation and chronic progressive CNS inflammationVeit Rothhammer, Jessica E Kenison, Emily Tjon, et al.
Journal of Neuroinflammation|January 7, 2022
MicroRNA-210 regulates the metabolic and inflammatory status of primary human astrocytesNicholas W Kieran, Rahul Suresh, Marie-France Dorion, et al.
Plos One|August 20, 2014
A novel microRNA-132-sirtuin-1 axis underlies aberrant B-cell cytokine regulation in patients with relapsing-remitting multiple sclerosis [corrected]Yusei Miyazaki, Rui Li, Ayman Rezk, et al.
Acta Neuropathologica|September 7, 2020
Extrinsic immune cell-derived, but not intrinsic oligodendroglial factors contribute to oligodendroglial differentiation block in multiple sclerosisLaura Starost, Maren Lindner, Martin Herold, et al.
Frontiers in Immunology|April 28, 2022
Contact-Dependent Granzyme B-Mediated Cytotoxicity of Th17-Polarized Cells Toward Human OligodendrocytesHélène Jamann, Qiao-Ling Cui, Haritha L Desu, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 2, 2017
Rapid and efficient generation of oligodendrocytes from human induced pluripotent stem cells using transcription factorsMarc Ehrlich, Sabah Mozafari, Michael Glatza, et al.
Pageof 10

Showing results (71-80 of 99) with videos related to

Sort By:
Pageof 10
Proceedings of the National Academy of Sciences of the United States of America|August 21, 2021
Pro-inflammatory T helper 17 directly harms oligodendrocytes in neuroinflammationCatherine Larochelle, Beatrice Wasser, Hélène Jamann, et al.
Annals of Neurology|October 23, 2009
Rituximab in patients with primary progressive multiple sclerosis: results of a randomized double-blind placebo-controlled multicenter trialKathleen Hawker, Paul O'Connor, Mark S Freedman, et al.
The New England Journal of Medicine|February 15, 2008
B-cell depletion with rituximab in relapsing-remitting multiple sclerosisStephen L Hauser, Emmanuelle Waubant, Douglas L Arnold, et al.
Immunology and Cell Biology|October 19, 2022
Granulocyte-macrophage colony-stimulating factor-stimulated human macrophages demonstrate enhanced functions contributing to T-cell activationNegar Farzam-Kia, Florent Lemaître, Ana Carmena Moratalla, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 8, 2017
Sphingosine 1-phosphate receptor modulation suppresses pathogenic astrocyte activation and chronic progressive CNS inflammationVeit Rothhammer, Jessica E Kenison, Emily Tjon, et al.
Journal of Neuroinflammation|January 7, 2022
MicroRNA-210 regulates the metabolic and inflammatory status of primary human astrocytesNicholas W Kieran, Rahul Suresh, Marie-France Dorion, et al.
Plos One|August 20, 2014
A novel microRNA-132-sirtuin-1 axis underlies aberrant B-cell cytokine regulation in patients with relapsing-remitting multiple sclerosis [corrected]Yusei Miyazaki, Rui Li, Ayman Rezk, et al.
Acta Neuropathologica|September 7, 2020
Extrinsic immune cell-derived, but not intrinsic oligodendroglial factors contribute to oligodendroglial differentiation block in multiple sclerosisLaura Starost, Maren Lindner, Martin Herold, et al.
Frontiers in Immunology|April 28, 2022
Contact-Dependent Granzyme B-Mediated Cytotoxicity of Th17-Polarized Cells Toward Human OligodendrocytesHélène Jamann, Qiao-Ling Cui, Haritha L Desu, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 2, 2017
Rapid and efficient generation of oligodendrocytes from human induced pluripotent stem cells using transcription factorsMarc Ehrlich, Sabah Mozafari, Michael Glatza, et al.
Pageof 10